Cargando…
Dynamic Changes in Neutrophil-to-Lymphocyte Ratio are Associated with Survival and Liver Toxicity Following Stereotactic Body Radiotherapy for Hepatocellular Carcinoma
PURPOSE: Immune response to antitumor therapies has been correlated with oncologic outcomes. This study aimed to determine whether dynamic changes in immune parameters could predict survival outcomes and assess their relationship with liver toxicity in hepatocellular carcinoma (HCC) patients treated...
Autores principales: | Hsiang, Chih-Weim, Huang, Wen-Yen, Yang, Jen-Fu, Shen, Po-Chien, Dai, Yang-Hong, Wang, Ying-Fu, Lin, Chun-Shu, Chang, Wei-Chou, Lo, Cheng-Hsiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8573140/ https://www.ncbi.nlm.nih.gov/pubmed/34765571 http://dx.doi.org/10.2147/JHC.S334933 |
Ejemplares similares
-
Prognostic Significance of Apparent Diffusion Coefficient in Hepatocellular Carcinoma Patients treated with Stereotactic Ablative Radiotherapy
por: Lo, Cheng-Hsiang, et al.
Publicado: (2019) -
Clinical outcome and pathologic correlation of stereotactic body radiation therapy as a bridge to transplantation for advanced hepatocellular carcinoma: a case series
por: Wang, Ying-Fu, et al.
Publicado: (2021) -
Stereotactic ablative radiotherapy versus conventionally fractionated radiotherapy in the treatment of hepatocellular carcinoma with portal vein invasion: a retrospective analysis
por: Yang, Jen-Fu, et al.
Publicado: (2019) -
Significant muscle loss after stereotactic body radiotherapy predicts worse survival in patients with hepatocellular carcinoma
por: Yang, Jen-Fu, et al.
Publicado: (2022) -
Survival and prognostic factors for patients with advanced hepatocellular carcinoma after stereotactic ablative radiotherapy
por: Lo, Cheng-Hsiang, et al.
Publicado: (2017)